FDA Clearance Tracker · P010047-S010
NEOMEND PROGEL PLEURAL AIR LEAK SEALANT
Last checked: Nov 20, 2026Latest source record: Dec 21, 2011 (this decision)Source: openFDAMethods & limitations
Decided
Dec 21, 2011
Approved
Time to decision
327 days
Received Jan 28, 2011. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P010047-S010
- Device name
- NEOMEND PROGEL PLEURAL AIR LEAK SEALANT
- Applicant
- Neomend, Inc.
- Applicant location
- Irvine, CA
- Received
- Jan 28, 2011
- Decided
- Dec 21, 2011
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P010047
Device type
- Device type
- Sealant, polymerizing (NBE)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE PROGEL APPLICATOR EXTENDED SPRAY TIPS AS AN ACCESSORY FOR THE PROGEL PLEURAL AIR LEAK SEALANT. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME PROGEL APPLICATOR EXTENDED SPRAY TIPS AND THE INDICATIONS FOR USE IS TO DELIVER PROGEL TO VISCERAL PLEURA DURING AN OPEN THORACOTOMY AFTER STANDARD VISCERAL PLEURAL CLOSURE (I.E. WITH SUTURES OR STAPLES) OF VISIBLE AIR LEAKS (>= 2 MM) INCURRED DURING OPEN RESECTION OF LUNG PARENCHYMA IN ADULT HUMANS BY BENDING THE MALLEABLE TIP TO DIRECT PROGEL FROM THE DELIVERY TIP IN A STREAM OR SPRAY CONE PATTERN THAT IS PERPENDICULAR TO THE TARGET SURFACE.
Source documents
Other decisions for Neomend, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P150016 · Decided Apr 11, 2016 · 350 days after receipt
Device type: Sealant, polymerizing (NBE) · Cardiology
- PROGEL PLEURAL AIR LEAK SEALANTPMA supplement
P010047-S036 · Decided Feb 13, 2015 · 217 days after receipt · Panel Track
Device type: Sealant, polymerizing (NBE) · Anesthesiology & Respiratory
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.